Pictet & Cie (Europe) Sa Insulet Corp Transaction History

Pictet & Cie (Europe) Sa

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	SELL	$276.36 - $326.03 $155,867 - $183,880	-564 Reduced 37.06%	958 $305,000
Q4 2022 Feb 08, 2023	SELL	$212.22 - $313.46 $52,206 - $77,111	-246 Reduced 13.91%	1,522 $0
Q2 2022 Aug 05, 2022	SELL	$186.4 - $279.02 $78,660 - $117,746	-422 Reduced 19.27%	1,768 $385,000
Q1 2022 May 04, 2022	BUY	$194.8 - $275.7 $98,179 - $138,952	504 Added 29.89%	2,190 $583,000
Q4 2021 Feb 02, 2022	SELL	$255.32 - $318.29 $106,723 - $133,045	-418 Reduced 19.87%	1,686 $449,000
Q3 2021 Nov 10, 2021	SELL	$260.36 - $307.27 $51,030 - $60,224	-196 Reduced 8.52%	2,104 $598,000
Q2 2021 Aug 11, 2021	BUY	$225.52 - $304.06 $221,235 - $298,282	981 Added 74.37%	2,300 $631,000
Q1 2021 May 10, 2021	BUY	$235.95 - $293.05 $311,218 - $386,532	1,319 New	1,319 $344,000

752

63.2M

475K

639K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $19.5B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Pictet & Cie (Europe) Sa, based on Form 13F filings with the SEC.

Stay updated on Pictet & Cie (Europe) Sa with notifications on news.